CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug

Related Companies

Read the original article

Published by yahoo_finance on July 14, 2026 3:14 PM

Read Original